From the Editors' Desk

Array Biopharma, Global Blood Therapeutics to Work on Hematological Drug Discovery

Array BioPharma Inc. and Global Blood Therapeutics today announced a multi-target drug discovery collaboration agreement to identify small molecule lead compounds targeting chronic blood-based diseases.  Array will develop assays and screen its...
AMAG Pharmaceuticals Attains FDA Acceptance on Supplemental Drug Application for Anemia Treatment

AMAG Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration has accepted for review the company’s supplemental new drug application for Feraheme Injection for Intravenous (IV) use, which was submitted to the...
European Medicines Agency Urges Action on Medication Errors

To tackle medication errors throughout the European Union, stakeholders in healthcare are being called upon to work together to improve reporting and prevention strategies. Collaboration is needed among national patient safety authorities,...
Pharma Companies Losing out on Billions Because of Non-Adherence, Report RxAdherence Speakers

Thomas Forissier favors an aggressive, comprehensive approach for tackling medication non-adherence, and for good reason. U.S. pharmaceutical companies are losing $188 billion each year because of non-adherence, according to analysis conducted by his...
Pharma Tech To Provide Start-To-Finish Services For OptiNose Delivery System
Pharma Tech Industries (PTI), Royston, GA (PTI), has been selected to handle filling, assembly, and packaging services for a migraine relief medication administered through the OptiNose Delivery system.
MD+DI Publishes Medical Device Outsourcing Market Study

Medical Device and Diagnostic Industry (MD+DI) and strategic alliance partner ITG Market Research, a division of ITG, recently published a landmark study on The Medical Device Outsourcing Landscape: Current & Future Trends, 2013-2018.  The...
Antares Pharma Attains FDA Acceptance of OTREXUP RA Drug Delivery System

Antares Pharma, Inc. today announced that the New Drug Application (NDA) for OTREXUP, a potential new product for the subcutaneous delivery of methotrexate (MTX) using Medi-Jet technology, has been accepted by the U.S. Food and Drug Administration (...
Sunovion Seizure Drug Accepted for FDA Review

Sunovion Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration has accepted for review the Company’s New Drug Application resubmission for STEDESA (eslicarbazepine acetate) for use as a once-daily adjunctive therapy in the...
MedVantx Introduces Direct-to-Consumer Prescription Delivery Channel

MedVantx Inc., the company that created the first ever controlled access to generic samples in US physician offices, today highlighted it's MedStart Connect program as a solution to the problem  specified in a recent study published in JAMA...
Araxes Pharma, Janssen Biotech to Partner on Cancer Drug Development

Araxes Pharma LLC announced today it has entered into an exclusive arrangement with Janssen Biotech, Inc. to develop first-in-class therapeutics against a certain target for the treatment of cancer.